For Institutions
- Corporate Services
- Developers
Download
Help
About

Markets

Information

Academy

Options & Futures

IPO Subscription

Structured Products

Investment Wiki

Affiliate Program

Promotions

EN

English

简体中文

繁體中文

繁體中文（廣東話）Posts & comments will be shown in Cantonese

Search...

Quote List Quote List

800医药(000841.SH)

© 2026 Longbridge｜Disclaimer

Event Tracking

Jan9

Schroders PLC Reduced Holdings in KaiLueTech to 5,741,800 Shares

11:55

Hengrui Medicine's Famataseran Capsule Marketing Authorization Application Accepted by NMPA

11:11

Jushi Biopharma's Chairman Xiong Jun Plans to Increase Holdings by at Least 100 Million Yuan in A and H Shares

09:18

Hengrui Medicine Receives Approval for Multiple Drugs Clinical Trials and Will Soon Start Clinical Trials

09:06

Hengrui's SHR-1701 Approved for Marketing, Becoming the First PD-L1/TGF- Antibody

05:39

CLSA Raises Target Price for Tigermed to HKD 57.2 and Reiterates Rating

02:48